GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Enzymatica AB (OSTO:ENZY) » Definitions » Total Liabilities

Enzymatica AB (OSTO:ENZY) Total Liabilities : kr23.00 Mil (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Enzymatica AB Total Liabilities?

Enzymatica AB's Total Liabilities for the quarter that ended in Mar. 2025 was kr23.00 Mil.

Enzymatica AB's quarterly Total Liabilities declined from Sep. 2024 (kr22.45 Mil) to Dec. 2024 (kr18.86 Mil) but then increased from Dec. 2024 (kr18.86 Mil) to Mar. 2025 (kr23.00 Mil).

Enzymatica AB's annual Total Liabilities increased from Dec. 2022 (kr48.12 Mil) to Dec. 2023 (kr49.30 Mil) but then declined from Dec. 2023 (kr49.30 Mil) to Dec. 2024 (kr18.86 Mil).


Enzymatica AB Total Liabilities Historical Data

The historical data trend for Enzymatica AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzymatica AB Total Liabilities Chart

Enzymatica AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55.38 32.07 48.12 49.30 18.86

Enzymatica AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.14 45.92 22.45 18.86 23.00

Enzymatica AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Enzymatica AB's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=17.833+(1.022+1.9984014443253E-15
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=18.86

Total Liabilities=Total Assets (A: Dec. 2024 )-Total Equity (A: Dec. 2024 )
=195.224-176.369
=18.86

Enzymatica AB's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities=Total Assets (Q: Mar. 2025 )-Total Equity (Q: Mar. 2025 )
=180.962-157.962
=23.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Enzymatica AB Total Liabilities Related Terms

Thank you for viewing the detailed overview of Enzymatica AB's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Enzymatica AB Business Description

Traded in Other Exchanges
N/A
Address
Scheelevagen 19, Delta 5, Ideon Science Park, Lund, SWE, SE-223 70
Enzymatica AB is a life science company that develops and sells medical devices against infectious diseases, based on a barrier technology, which includes marine enzymes. Its product ColdZyme Mouth Spray prevents cold and reduces disease period.

Enzymatica AB Headlines

From GuruFocus

Julian Robertson Adds to Multiple Positions in 3rd quarter

By Tiziano Frateschi Tiziano Frateschi 12-20-2016

Tiger Management Founder Julian Robertson Ups Stake in Enzymotec

By Kyle Ferguson Kyle Ferguson 12-07-2015

Julian Robertson Cuts Half of Stake in Paulson-Backed Company

By Holly LaFon Holly LaFon 07-01-2016